Capital and reserves attributable to the Company’s equity holders
Non-controlling interests
Total equity
Lease liabilities
Interest-bearing loans and borrowings
Deferred income tax liabilities
Other payables
Retirement benefit obligations
Provisions for liabilities
Total non-current liabilities
Trade and other payables
Current income tax liabilities
Liabilities associated with assets classified as held for sale
Total current liabilities
Total liabilities
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable, net of allowance for credit losses of $136 million, $137 million, and $158 million as of September 30, 2026, December 31, 2025, and September 30, 2025, respectively
Inventories
Assets held for sale
Other current assets
Total current assets
Property, plant and equipment, net
Equity method investments
Goodwill
Intangible assets, net
Operating lease right-of-use assets, net
Other noncurrent assets
Total assets
Liabilities, redeemable noncontrolling interests and shareholders’ equity
Current liabilities:
Accounts payable
Accrued expenses
Current portion of long-term debt
Operating lease liabilities
Liabilities held for sale
Other current liabilities
Total current liabilities
Long-term debt
Deferred income tax liabilities
Noncurrent operating lease liabilities
Other noncurrent liabilities
Total liabilities
Redeemable noncontrolling interests
Shareholders’ equity
Preferred stock, €1.27 par value, nil, 150,000 and 150,000 shares authorized and nil, 50,000 and 50,000 shares issued and outstanding for 5% preferred stock and nil, 872,000 and 872,000 shares authorized, issued and outstanding for 7% 'A' preferred stock, as of September 30, 2026, December 31, 2025, and September 30, 2025, respectively
Common stock, €0.32 par value, 1,250,000,000 shares authorized; 700,688,292, 706,946,142 and 709,054,314 issued and 665,097,488, 668,630,350 and 670,472,746 outstanding, as of September 30, 2026, December 31, 2025, and September 30, 2025, respectively
Treasury stock, at cost (35,590,804, 38,315,792 and 38,581,568 shares of common stock as of September 30, 2026, December 31, 2025, and September 30, 2025, respectively)
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings
Total shareholders’ equity attributable to CRH shareholders
Noncontrolling interests
Total equity
Total liabilities, redeemable noncontrolling interests and equity